Cargando…
The resolution of carotid arterial thrombus by oral anticoagulation after IV thrombolysis for chemotherapy-induced stroke: A case report
RATIONALE: Cancer-related stroke has been regarded as an emerging subtype of ischemic event. Acute treatment for this subtype may include the antiplatelet agents, anticoagulants, or endovascular intervention. PATIENT CONCERNS: A 63-year-old woman with sudden-onset right hemiparesis and conscious cha...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458174/ https://www.ncbi.nlm.nih.gov/pubmed/32871929 http://dx.doi.org/10.1097/MD.0000000000021922 |
_version_ | 1783576139557502976 |
---|---|
author | Wu, Bo-Chang Hu, Ming-Hung Wang, Vinchi |
author_facet | Wu, Bo-Chang Hu, Ming-Hung Wang, Vinchi |
author_sort | Wu, Bo-Chang |
collection | PubMed |
description | RATIONALE: Cancer-related stroke has been regarded as an emerging subtype of ischemic event. Acute treatment for this subtype may include the antiplatelet agents, anticoagulants, or endovascular intervention. PATIENT CONCERNS: A 63-year-old woman with sudden-onset right hemiparesis and conscious change was sent to our emergency department. The patient had underlying sigmoid adenocarcinoma and received chemotherapy FOLFIRI (FOL, folinic acid; F, fluorouracil; and IRI, irinotecan) with targeted therapy cetuximab following lower anterior resection since the diagnosis was made. DIAGNOSES: Brain magnetic resonance angiography revealed a filling defect in left carotid bulb, and neurosonography showed a thick atherosclerotic plaque (size 4.9 mm) in the left internal carotid artery on day 5 after the onset of stroke. INTERVENTIONS: During the first three hours after onset, administration of IV tissue plasminogen activator did not resolve the thrombus. Dabigatran (110 mg bid) started on day 7. OUTCOMES: The atherosclerotic plaque dissolved on day 24. The patient recovered her muscle strength but still had nonfluent speech in mild extent. LESSONS: Thrombolytic and anticoagulant medications in this patient suggested the thrombus formation with fibrin-rich content which may be attributable to both cancer and chemotherapy. Dabigatran, an oral anticoagulant, had a benefit for this subtype of ischemic stroke among patients with cancer. |
format | Online Article Text |
id | pubmed-7458174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-74581742020-09-11 The resolution of carotid arterial thrombus by oral anticoagulation after IV thrombolysis for chemotherapy-induced stroke: A case report Wu, Bo-Chang Hu, Ming-Hung Wang, Vinchi Medicine (Baltimore) 5300 RATIONALE: Cancer-related stroke has been regarded as an emerging subtype of ischemic event. Acute treatment for this subtype may include the antiplatelet agents, anticoagulants, or endovascular intervention. PATIENT CONCERNS: A 63-year-old woman with sudden-onset right hemiparesis and conscious change was sent to our emergency department. The patient had underlying sigmoid adenocarcinoma and received chemotherapy FOLFIRI (FOL, folinic acid; F, fluorouracil; and IRI, irinotecan) with targeted therapy cetuximab following lower anterior resection since the diagnosis was made. DIAGNOSES: Brain magnetic resonance angiography revealed a filling defect in left carotid bulb, and neurosonography showed a thick atherosclerotic plaque (size 4.9 mm) in the left internal carotid artery on day 5 after the onset of stroke. INTERVENTIONS: During the first three hours after onset, administration of IV tissue plasminogen activator did not resolve the thrombus. Dabigatran (110 mg bid) started on day 7. OUTCOMES: The atherosclerotic plaque dissolved on day 24. The patient recovered her muscle strength but still had nonfluent speech in mild extent. LESSONS: Thrombolytic and anticoagulant medications in this patient suggested the thrombus formation with fibrin-rich content which may be attributable to both cancer and chemotherapy. Dabigatran, an oral anticoagulant, had a benefit for this subtype of ischemic stroke among patients with cancer. Lippincott Williams & Wilkins 2020-08-28 /pmc/articles/PMC7458174/ /pubmed/32871929 http://dx.doi.org/10.1097/MD.0000000000021922 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 5300 Wu, Bo-Chang Hu, Ming-Hung Wang, Vinchi The resolution of carotid arterial thrombus by oral anticoagulation after IV thrombolysis for chemotherapy-induced stroke: A case report |
title | The resolution of carotid arterial thrombus by oral anticoagulation after IV thrombolysis for chemotherapy-induced stroke: A case report |
title_full | The resolution of carotid arterial thrombus by oral anticoagulation after IV thrombolysis for chemotherapy-induced stroke: A case report |
title_fullStr | The resolution of carotid arterial thrombus by oral anticoagulation after IV thrombolysis for chemotherapy-induced stroke: A case report |
title_full_unstemmed | The resolution of carotid arterial thrombus by oral anticoagulation after IV thrombolysis for chemotherapy-induced stroke: A case report |
title_short | The resolution of carotid arterial thrombus by oral anticoagulation after IV thrombolysis for chemotherapy-induced stroke: A case report |
title_sort | resolution of carotid arterial thrombus by oral anticoagulation after iv thrombolysis for chemotherapy-induced stroke: a case report |
topic | 5300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458174/ https://www.ncbi.nlm.nih.gov/pubmed/32871929 http://dx.doi.org/10.1097/MD.0000000000021922 |
work_keys_str_mv | AT wubochang theresolutionofcarotidarterialthrombusbyoralanticoagulationafterivthrombolysisforchemotherapyinducedstrokeacasereport AT huminghung theresolutionofcarotidarterialthrombusbyoralanticoagulationafterivthrombolysisforchemotherapyinducedstrokeacasereport AT wangvinchi theresolutionofcarotidarterialthrombusbyoralanticoagulationafterivthrombolysisforchemotherapyinducedstrokeacasereport AT wubochang resolutionofcarotidarterialthrombusbyoralanticoagulationafterivthrombolysisforchemotherapyinducedstrokeacasereport AT huminghung resolutionofcarotidarterialthrombusbyoralanticoagulationafterivthrombolysisforchemotherapyinducedstrokeacasereport AT wangvinchi resolutionofcarotidarterialthrombusbyoralanticoagulationafterivthrombolysisforchemotherapyinducedstrokeacasereport |